Vera Therapeutics VERA Return on equity

Return on equity at other companies

Vertex PharmaceuticalsVRTX

23.5%—

Travere Therapeutics, Inc.TVTX

-706%-1,302pp

Aurinia PharmaceuticalsAUPH

66.1%+48.8pp

Climb Bio, Inc.CLYM

-30.9%-10.3pp

Jade BiosciencesJBIO

-132.5%+120pp

Viridian Therapeutics, Inc.VRDN

-65.7%-0.1pp

FAQ

What is Vera Therapeutics's return on equity?

Vera Therapeutics (VERA) reported return on equity of -71.3% in Q1 2026.

How has Vera Therapeutics's return on equity changed year-over-year?

Vera Therapeutics's return on equity decreased by 80.6% year-over-year, from -39.5% to -71.3%.

What is the long-term trend for Vera Therapeutics's return on equity?

Over 3 years (2022 to 2025), Vera Therapeutics's return on equity has grown at a -25.3% compound annual growth rate (CAGR), from -121.6% to -50.7%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.